Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Andre Pectin is a China-based manufacturer of pectin ingredients used primarily in food, beverage, nutrition, and certain health supplement applications. Founded in 2003 in Yantai, Shandong, the company produces apple and citrus pectin, including HM, LMA, and LMC grades, for use in jams, jellies, confectionery, dairy, beverages, bakery products, and related formulations. The business appears to be an operating commercial manufacturing company rather than a therapeutic biotech or pharmaceutical developer. In 2025, dsm-firmenich increased its ownership stake in the company to 90.5%, making the business effectively a majority-controlled subsidiary while leaving a minority stake with Rich Spring Holdings Limited. For biotech and pharma classification purposes, the company is better categorized as a specialty ingredient manufacturer than as a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai Andre Pectin.